It is no secret that the UK’s National Health Service (NHS), like many other healthcare systems, is under pressure on ...

Philips has announced the expansion of its collaboration with Medtronic, focusing on advancing patient monitoring ...

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.

Proteomics International Laboratories has secured a patent from the Japan Patent Office for the PromarkerEndo test for ...

2 million individuals in the US live with type 1 diabetes and a rising number of type 2 patients require basal-bolus insulin therapy. Credit: Halfpoint via Shutterstock. The integration of Abbott’s ...

Carmat requires €3.5m “urgently” and around €35m over the next 12 months to continue operations. Image credit: ArtemisDiana via Shutterstock. France-based Carmat has filed for insolvency and requested ...

In the trial, patients experienced a 24-point improvement in their Kansas City Cardiomyopathy Questionnaire score. Credit: Jo Panuwat D / Shutterstock. Foldax has revealed one-year outcomes from the ...

Medtronic Diabetes has entered a partnership with professional tennis player Alexander Zverev to launch “Life Without Limits” – a global awareness campaign aimed at highlighting how diabetes ...

The platform aims to minimise the requirement of several clinicians during procedures, which is especially beneficial amidst nurse shortages. Credit: Robert Kneschke / Shutterstock. NanoVibronix has ...

With profound change in sight for the UK’s National Health Service (NHS), a new report indicates that a technology-driven ...

Carlsmed looks set to join the 2025 class of medtechs going public, though it has not yet set its share price range.

Glaukos has secured EU Medical Device Regulation (EU-MDR) certification for its iStent infinite, along with other MIGS ...